Kyle W. Keese
2011
In 2011, Kyle W. Keese earned a total compensation of $1.2M as Executive Vice President, Biosciences Division at Emergent BioSolutions, a 48% increase compared to previous year.
Compensation breakdown
| Option Awards | $236,927 |
|---|---|
| Salary | $225,098 |
| Stock Awards | $255,942 |
| Other | $448,745 |
| Total | $1,166,712 |
Keese received $448.7K in other compensation, accounting for 38% of the total pay in 2011.
Keese also received $236.9K in option awards, $225.1K in salary and $255.9K in stock awards.
Rankings
In 2011, Kyle W. Keese's compensation ranked 5,092nd out of 10,747 executives tracked by ExecPay. In other words, Keese earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,092 out of 10,747 | 53rd |
Division Manufacturing | 1,837 out of 3,960 | 54th |
Major group Chemicals And Allied Products | 387 out of 1,033 | 63rd |
Industry group Drugs | 240 out of 781 | 69th |
Industry Pharmaceutical Preparations | 189 out of 571 | 67th |
Source: SEC filing on April 6, 2012.
Keese's colleagues
We found six more compensation records of executives who worked with Kyle W. Keese at Emergent BioSolutions in 2011.
2011
Fuad El-Hibri
Emergent BioSolutions
Chairman
2011
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2011
Adam Havey
Emergent BioSolutions
Executive Vice President, Biodefense Division
2011
R Elsey
Emergent BioSolutions
Chief Financial Officer
2011
Steven Chatfield
Emergent BioSolutions
Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division
2011
Steve Chatfield
Emergent BioSolutions